Follow
Anja Sandström
Anja Sandström
Unknown affiliation
Verified email at orgfarm.uu.se
Title
Cited by
Cited by
Year
Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals
A Johansson, A Poliakov, E Åkerblom, K Wiklund, G Lindeberg, ...
Bioorganic & medicinal chemistry 11 (12), 2551-2568, 2003
1752003
Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses
A Luttens, H Gullberg, E Abdurakhmanov, DD Vo, D Akaberi, VO Talibov, ...
Journal of the American Chemical Society 144 (7), 2905-2920, 2022
1502022
Vinyl Sulfide Cyclized Analogues of Angiotensin II with High Affinity and Full Agonist Activity at the AT1 Receptor
P Johannesson, G Lindeberg, A Johansson, GV Nikiforovich, A Gogoll, ...
Journal of medicinal chemistry 45 (9), 1767-1777, 2002
1502002
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3
R Rönn, YA Sabnis, T Gossas, E Åkerblom, UH Danielson, A Hallberg, ...
Bioorganic & medicinal chemistry 14 (2), 544-559, 2006
862006
Synthesis of novel aryl and heteroaryl acyl sulfonimidamides via Pd-catalyzed carbonylation using a nongaseous precursor
SR Borhade, A Sandstrom, PI Arvidsson
Organic letters 15 (5), 1056-1059, 2013
742013
Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors
P Örtqvist, SD Peterson, E Åkerblom, T Gossas, YA Sabnis, R Fransson, ...
Bioorganic & medicinal chemistry 15 (3), 1448-1474, 2007
632007
Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors
R Rönn, T Gossas, YA Sabnis, H Daoud, E Åkerblom, UH Danielson, ...
Bioorganic & medicinal chemistry 15 (12), 4057-4068, 2007
592007
Preclinical characterization of acyl sulfonimidamides: potential carboxylic acid bioisosteres with tunable properties
SR Borhade, R Svensson, P Brandt, P Artursson, PI Arvidsson, ...
ChemMedChem 10 (3), 455-460, 2015
542015
Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain
A Johansson, I Hubatsch, E Åkerblom, G Lindeberg, S Winiwarter, ...
Bioorganic & medicinal chemistry letters 11 (2), 203-206, 2001
502001
Tetrapeptides as potent protease inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase)
A Johansson, A Poliakov, E Åkerblom, G Lindeberg, S Winiwarter, ...
Bioorganic & medicinal chemistry 10 (12), 3915-3922, 2002
492002
An improved procedure for N-to C-directed (Inverse) solid-phase peptide synthesis
A Johansson, E Åkerblom, K Ersmark, G Lindeberg, A Hallberg
Journal of combinatorial chemistry 2 (5), 496-507, 2000
482000
Structure–activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
A Poliakov, A Johansson, E Åkerblom, K Oscarsson, B Samuelsson, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1672 (1), 51-59, 2004
462004
New developments in the discovery of agents to treat hepatitis C
R Ronn, A Sandstrom
Current Topics in Medicinal Chemistry 8 (7), 533-562, 2008
442008
Palladium-catalyzed aminocarbonylation in solid-phase peptide synthesis: a method for capping, cyclization, and isotope labeling
A Skogh, SD Friis, T Skrydstrup, A Sandström
Organic letters 19 (11), 2873-2876, 2017
382017
A straightforward microwave method for rapid synthesis of N-1, C-6 functionalized 3, 5-dichloro-2 (1 H)-pyrazinones
J Gising, P Örtqvist, A Sandström, M Larhed
Organic & Biomolecular Chemistry 7 (13), 2809-2815, 2009
372009
A straightforward microwave method for rapid synthesis of N-1, C-6 functionalized 3, 5-dichloro-2 (1 H)-pyrazinones
J Gising, P Örtqvist, A Sandström, M Larhed
Organic & Biomolecular Chemistry 7 (13), 2809-2815, 2009
372009
Small peptides mimicking substance P (1–7) and encompassing a C-terminal amide functionality
R Fransson, M Botros, F Nyberg, G Lindeberg, A Sandström, M Hallberg
Neuropeptides 42 (1), 31-37, 2008
302008
Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3
G Dahl, A Sandström, E Åkerblom, UH Danielson
The FEBS Journal 274 (22), 5979-5986, 2007
302007
Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3
G Dahl, A Sandström, E Åkerblom, UH Danielson
Antiviral therapy 12 (5), 733-740, 2007
292007
Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocket
J Gising, AK Belfrage, H Alogheli, A Ehrenberg, E Åkerblom, R Svensson, ...
Journal of Medicinal Chemistry 57 (5), 1790-1801, 2014
282014
The system can't perform the operation now. Try again later.
Articles 1–20